Shandong Weigao reports H share repurchases, updates treasury share movements

Shandong Weigao Group Medical Polymer Company Limited submitted a Next Day Disclosure Return on December 1, 2025, detailing a repurchase of 80,000 H shares on the Exchange. The shares were repurchased at prices ranging from HK$5.54 to HK$5.55, with an aggregate price paid of HK$443,800. These shares are being held as treasury shares.

The repurchase resulted in the number of issued shares (excluding treasury shares) decreasing from 4,495,116,324 to 4,495,036,324, and the number of treasury shares increasing from 27,216,000 to 27,296,000. The total number of issued shares remains 4,522,332,324. The repurchase, representing 0.0018% of existing issued shares (excluding treasury shares), was authorized by a resolution on May 27, 2025, with a mandate to repurchase up to 451,560,392 shares.

The company's Monthly Return for November 2025 further indicates a monthly decrease of 4,933,200 in issued H shares and a corresponding increase in H treasury shares. This includes various repurchases from November 3 to November 28, 2025, at prices between HK$5.2587 and HK$5.6325. The total authorized/registered share capital for H shares remains RMB 452,233,232.4, and for non-listed shares, RMB 4,830,000.